All the top Biotech & Pharma news in one daily newsletter.

Want to understand how these updates are formatted? Check-out the FAQ.

Have any feedback? I’d love to hear you from - connect with me on LinkedIn. 📣

THE GOOD
Business Development & Partnerships

NewAmsterdam partners with Caristo for AI-powered imaging in phase 3 cholesterol drug trial
Research collaboration, cardiovascular, AI/ML, small molecule, global - Read more

Boehringer Ingelheim, AimedBio partner on ADC licensing deal worth $991M total
Licensing deal, oncology, antibody-drug conjugate, milestone payments - Read more

Novo Nordisk, Omeros partner on rare disease drug zaltenibart for up to $2.1B total
Licensing deal, rare disease, antibody, milestone payments - Read more

Alanis Therapeutics, Blood Cancer United collaborate on Notch-1 targeting therapy for MDS/AML patients
Research collaboration, oncology, antibody, drug discovery - Read more

PharmaMar receives $50M milestone from Jazz for Zepzelca FDA approval
Licensing deal, oncology, small molecule, milestone payments - Read more

PRESENTED BY YOU?
Get the attention of 2300+ Biotech & Pharma Professionals 🤩

Do you offer a biotech/pharma-focused product or service?

Or looking to get investor/analyst interest on your budding start-up?

Considering sponsoring TLDR Biotech to get in-front of an engaged audience of biotech & pharma-focused professionals.

Just reply to this email* or message me on LinkedIn to learn more.

*If you’re reading this on the web version, email [email protected]

✅ More Good News ✅

THE GOOD
Clinical Trials

Eli Lilly's Orforglipron GLP-1 pill hits Ph3 endpoints for type 2 diabetes, regulatory filing planned 2025
Small molecule, metabolic, GLP-1 agonist, type 2 diabetes, obesity - Read more

Adocia, Tonghua Dongbao report positive Ph3 results for biochaperone lispro ultra-rapid insulin in type 1 diabetes
Protein therapy, metabolic, insulin, type 1 diabetes, postprandial glucose control - Read more

Eradivir's EV25 shows promising Ph2a results for influenza treatment, reducing viral loads and symptoms
Small molecule, infectious disease, influenza, viral load reduction, immune system modulator - Read more

THE GOOD
Fundraises

Tubulis raises $361M Series C, antibody-drug conjugate developer targeting ovarian and lung cancer
Oncology, antibody-drug conjugate, clinical-stage, cancer - Read more

Pelage Pharmaceuticals raises $120M Series B, regenerative hair loss therapy development
Regenerative therapy, hair loss, topical treatment, clinical-stage - Read more

Step Pharma raises €38M ($44.1M) Series C, CTPS1 inhibitor for targeted cancer treatment
Oncology, small molecule, CTPS1 inhibition, clinical-stage - Read more

Mission Therapeutics raises $13.3M funding, advancing Parkinson's candidate MTX325 through trials
Clinical-stage, neurological, Parkinson disease, mitophagy, small molecule - Read more

Bexorg raises $23M Series A, AI-driven human brain platform for CNS drug discovery
Neurological, AI/ML platform, drug discovery, platform technology, CNS - Read more

Propanc Biopharma raises $100M strategic financing, accelerating clinical pipeline development
Cancer, clinical-stage - Read more

Annovis raises $6M registered direct offering, neurodegenerative disease therapeutics platform
Neurological, Alzheimer disease, Parkinson disease, clinical-stage, platform technology - Read more

Liberate Bio raises $31M seed, in vivo cell therapies targeting monocytes/macrophages
Cell therapy, oncology, lipid nanoparticles, in vivo delivery, preclinical - Read more [Paywall]

Omnix Medical raises $25M Series C, developing anti-infectives for life-threatening infections
Infectious disease, antimicrobial peptides, clinical-stage, gram-negative bacteria - Read more

NIHR invests £157M ($209.2M) over 5 years in 10 new applied research collaborations across England
Applied research, multiple disease areas, strategic, major investment - Read more

EyePoint raises $150M public offering, advancing retinal disease therapeutics including DURAVYU
Retinal diseases, ophthalmology, clinical-stage, DURAVYU - Read more

THE GOOD
Investments

AstraZeneca invests $445M to double Lokelma production capacity at Texas manufacturing facility
Small molecule, cardiovascular, operational, major transaction, strategic - Read more

THE GOOD
Lawsuits

GSK, Scynexis resolve Brexafemme trial dispute with $22M settlement, wind down phase 3 study
Licensing deal, infectious disease, milestone payments, manufacturing - Read more

THE GOOD
Mergers & Acquisitions

Particle Dynamics, EuroAPI merge facilities to launch Codis CDMO with 5,000-ton spray drying capacity
Acquisition, manufacturing, CDMO, global - Read more

THE BAD
No Bad News Today!

THE UGLY
No Ugly News Today!

You’re all caught up on the latest Pharma & Biotech News!

TLDR Biotech wants to hear from you! 📣

Have comments/questions/complaints about this newsletter?
Send me an email - I want your brutally honest feedback. 📝

If you find the content useful and think a colleague would too, please share TLDR Biotech with them! ♻️

And lastly - connect with me on LinkedIn!

Disclaimer: Content, news, research, tools, and mention of stock or tradeable securities are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here